Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region

NCT04845984 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2021-04-15

No results posted yet for this study

Summary

The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.

Conditions

  • Covid19
  • Health Care Worker

Sponsors & Collaborators

  • Centre Hospitalier Annecy Genevois

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-01-15
Completion
2021-01-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845984 on ClinicalTrials.gov